These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glycomimetic inhibitors of tandem-repeat galectins: Simple and efficient. Vrbata D; Červený J; Kulik N; Hovorková M; Balogová S; Vlachová M; Pelantová H; Křen V; Bojarová P Bioorg Chem; 2024 Apr; 145():107231. PubMed ID: 38394919 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951 [TBL] [Abstract][Full Text] [Related]
5. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting. Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179 [TBL] [Abstract][Full Text] [Related]
6. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure. Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394 [TBL] [Abstract][Full Text] [Related]
7. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis. Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851 [TBL] [Abstract][Full Text] [Related]
8. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1. van Hattum H; Branderhorst HM; Moret EE; Nilsson UJ; Leffler H; Pieters RJ J Med Chem; 2013 Feb; 56(3):1350-4. PubMed ID: 23281927 [TBL] [Abstract][Full Text] [Related]
9. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Stannard KA; Collins PM; Ito K; Sullivan EM; Scott SA; Gabutero E; Darren Grice I; Low P; Nilsson UJ; Leffler H; Blanchard H; Ralph SJ Cancer Lett; 2010 Dec; 299(2):95-110. PubMed ID: 20826047 [TBL] [Abstract][Full Text] [Related]
10. Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimers. Miller MC; Ludwig AK; Wichapong K; Kaltner H; Kopitz J; Gabius HJ; Mayo KH Biochem J; 2018 Mar; 475(5):1003-1018. PubMed ID: 29321242 [TBL] [Abstract][Full Text] [Related]
11. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8. Oberg CT; Blanchard H; Leffler H; Nilsson UJ Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029 [TBL] [Abstract][Full Text] [Related]
12. Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3. Wolfenden M; Cousin J; Nangia-Makker P; Raz A; Cloninger M Molecules; 2015 Apr; 20(4):7059-96. PubMed ID: 25903363 [TBL] [Abstract][Full Text] [Related]
13. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen. Bian CF; Zhang Y; Sun H; Li DF; Wang DC PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831 [TBL] [Abstract][Full Text] [Related]
14. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3. Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296 [TBL] [Abstract][Full Text] [Related]
15. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity. Peterson K; Kumar R; Stenström O; Verma P; Verma PR; Håkansson M; Kahl-Knutsson B; Zetterberg F; Leffler H; Akke M; Logan DT; Nilsson UJ J Med Chem; 2018 Feb; 61(3):1164-1175. PubMed ID: 29284090 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance. Kim H; Weidner N; Ronin C; Klein E; Roper JA; Kahl-Knutson B; Peterson K; Leffler H; Nilsson UJ; Pedersen A; Zetterberg FR; Slack RJ SLAS Discov; 2023 Jul; 28(5):233-239. PubMed ID: 36990319 [TBL] [Abstract][Full Text] [Related]
17. Quaternary solution structures of galectins-1, -3, and -7. Morris S; Ahmad N; André S; Kaltner H; Gabius HJ; Brenowitz M; Brewer F Glycobiology; 2004 Mar; 14(3):293-300. PubMed ID: 14693909 [TBL] [Abstract][Full Text] [Related]
18. Varied expression and localization of multiple galectins in different cancer cell lines. Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388 [TBL] [Abstract][Full Text] [Related]
19. Role of Galectins in Tumors and in Clinical Immunotherapy. Chou FC; Chen HY; Kuo CC; Sytwu HK Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859 [TBL] [Abstract][Full Text] [Related]
20. Role of Galectins in Multiple Myeloma. Storti P; Marchica V; Giuliani N Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]